Nano-Hydroxyapatite Composite Scaffolds Loaded with Bioactive Factors and Drugs for Bone Tissue Engineering

Int J Mol Sci. 2023 Jan 9;24(2):1291. doi: 10.3390/ijms24021291.

Abstract

Nano-hydroxyapatite (n-HAp) is similar to human bone mineral in structure and biochemistry and is, therefore, widely used as bone biomaterial and a drug carrier. Further, n-HAp composite scaffolds have a great potential role in bone regeneration. Loading bioactive factors and drugs onto n-HAp composites has emerged as a promising strategy for bone defect repair in bone tissue engineering. With local delivery of bioactive agents and drugs, biological materials may be provided with the biological activity they lack to improve bone regeneration. This review summarizes classification of n-HAp composites, application of n-HAp composite scaffolds loaded with bioactive factors and drugs in bone tissue engineering and the drug loading methods of n-HAp composite scaffolds, and the research direction of n-HAp composite scaffolds in the future is prospected.

Keywords: bioactive factor; bone regeneration; composite scaffold; drug delivery; nano-hydroxyapatite.

Publication types

  • Review

MeSH terms

  • Biocompatible Materials / chemistry
  • Biocompatible Materials / pharmacology
  • Drug Carriers
  • Durapatite* / chemistry
  • Humans
  • Tissue Engineering*
  • Tissue Scaffolds / chemistry

Substances

  • Durapatite
  • Biocompatible Materials
  • Drug Carriers